Replies to post #122125 on Biotech Values

[genisi]

Eliquis (apixaban)

In ARISTOTLE, Eliquis went head-to-head against warfarin and was statsig superior on both efficacy and safety. No HR or p-value was disclosed today; full data will be presented at the ESC conference in August.

I guess results are on an ITT basis but we'll know that by Aug. as well.